Cyclic adenosine 3', 5' monophosphate (cyclic-AMP) has been estimated in mucosal biopsy samples removed from the descending colon and rectum at endoscopy to investigate the possibility of using this substance for monitoring pre-malignant changes in the large bowel. Four groups of patients have been studied: those with normal large bowel and rectal mucosa; those with non-malignant inflammatory bowel disease; those with an adenomatous polyp in the descending colon or sigmoid colon; and those with a rectal adenocarcinoma. No difference was found in the cyclic-AMP content of 'normal' rectal mucosa, 'normal' colonic mucosa, 'diseased' colonic mucosa, carcinomas, and uninvolved mucosa adjacent to the polyps. Less cyclic-AMP was found in the polyps than in adjacent uninvolved mucosa. Conversely, more cyclic-AMP was found in the carcinomas than in adjacent uninvolved mucosa. It is concluded that although cyclic-AMP may be a very useful parameter for delineating the extent of the disease in individual patients, it is not a suitable biochemical marker for the screening of neoplastic changes in the large bowel in the population asa whole.
Materials and methods
Colorectal biopsy specimens were obtained from four groups of individuals who were examined at an endoscopy clinic because of previous rectal bleeding or diarrhoea. The first group consisted of patients who were found to have a normal large bowel and rectum; the second consisted of patients who were found to have a non-malignant inflammatory disease of the colon (Crohn's disease, ulcerative proctitis, or ulcerative colitis); the third consisted of patients who were found to have a polyp either in the descending colon or in the rectosigmoid region; and the fourth consisted of patients who were found to have a rectal carcinoma. These different groups were designated 'normal ', 'diseased', 'polyp', and 'carcinoma' respectively. In all cases, the clinical diagnosis was confirmed histologically.
Biopsy specimens (usually 3-15 mg) were taken with biopsy forceps using either a colonoscope or a sigmoidoscope. In the 'polyp' and 'carcinoma' groups, both involved and uninvolved mucosae were biopsied. The pieces of uninvolved tissue were removed, on average, 3--4 em from the site of the lesion. In 60% of the individuals in the 'normal' group, biopsy specimens of both the descending 127 More successful early detection of premalignant changes in large bowel mucosa would help to improve the present survival figures for colorectal cancer. Currently available methods rely strongly on visual and radiological detection of early abnormalities followed by histological investigation of the subsequent biopsy specimens. However, even if a lesion is detected, this approach has many severe limitations, notably, the problem of how to define accurately the unaffected area, which may appear histologically normal but which may have started on the path to malignancy. Thus, a pressing need exists for a biochemical marker to detect these early changes (Medical Research Council and Health Department, 1977) .
One such possible marker is the cyclic nucleotide cyclic adenosine 3',5' monophosphate (cyclic-AMP). There is considerable evidence from tissue culture studies that this substance is an important determinant of cell growth and differentiation (Ryan and Heidrick, 1974) . According to these studies, a reduction in cyclic-AMP might be predicted in tissue that has undergone any change towards malignancy. The present study was undertaken to investigate the possibility of using this substance as a marker in the early diagnosis of colorectal cancer. specimens obtained from the different groups of patients. No significant differences were observed between the levels in 'normal' rectal mucosa, 'normal' colonic mucosa, 'diseased' colonic mucosa, carcinomas, and uninvolved mucosa from the 'polyp' group. However, significantly less cyclic-AMP was found in the polyps than in the adjacent uninvolved mucosa. Conversely, the carcinomas appeared to contain more cyclic-AMP than their adjacent uninvolved mucosa, but this difference was just not significant at the 5 % level. Unexpectedly, the uninvolved mucosa from the 'carcinoma' group contained significantly less cyclic-AMP than that found in 'normal' rectal mucosa. cyclic-AMP levels of uninvolved and involved tissue from the 'polyp' and 'carcinoma' groups were compared on a paired basis. In the 'polyp' group, 85 % of the patients had lower cyclic-AMP levels in the polyp than in normal tissue, whereas in the 'carcinoma' group, 70% of the patients had a higher cyclic-AMP level in the tumour. Both these changes were shown to be very significant using the Wilcoxon's paired analysis.
Discussion
In the 'polyp' group, no correlation was found between the cyclic-AMP level in the involved and uninvolved specimens and the degree of atypia in the involved tissue. In the 'carcinoma' group, no correlation was found between the cyclic-AMP level in the involved or uninvolved specimens and the size, degree of differentiation, or grading of the tumour.
Results colon and rectum were removed. Within 30 seconds specimens were frozen in liquid Freon maintained at -78°C and eventually stored at -70°C until required for assay. A portion of each specimen was used for histology.
Using currently accepted histological criteria (Ackerman and Rosai, 1974) , all polyps investigated were classified as adenomatous and all tumours as adenocarcinomas. The latter were graded as either B or C (Dukes, 1932) ; all measured greater than 2 em in one dimension, the majority measuring greater than 5 em. Any pair of biopsy specimens (uninvolved and involved) were excluded from the investigation if the uninvolved specimen was histologically different from normal mucosa.
The cyclic-AMP was extracted by homogenising the frozen material at 0_4°C in 1 ml 5% (wjv) trichloroacetic acid (TCA) containing a trace amount of radioactive cyclic-AMP to monitor recovery. The homogenate was separated by centrifugation at top speed on a bench centrifuge, and the supernatant was extracted four times with four volumes of watersaturated diethyl ether to remove the TCA. The extract was freeze-dried and reconstituted in 0-4 ml Tris{HCI buffer (50 mmolfl), pH 7'4, containing theophylline (8 mmolfl) and 2-mercaptoethanol (6 mmoljl). The amount of protein in the TCAprecipitate was estimated using the method of Lowry et al. (1951) .
Cyclic-AMP was assayed by a protein-binding method, as previously described (Latner and Prudhoe, 1973) . All specimens were assayed blind. The detection-limit of this method is 0·25 pmol and its precision is ± 0·2 prnol (Latner and Prudhoe, 1973) . Results were expressed as pmol cyclic-AMP per mg protein. All differences between groups were analysed statistically using either the Student's t test or the Wilcoxon's paired analysis. Table 1 shows the mean cyclic-AMP levels in biopsy Our results suggest that cyclic-AMP may be a possible indicator of premalignant changes in the large bowel. Altered cyclic-AMP levels were found only in polyps and histologically 'normal' mucosa adjacent to carcinomas. Although some controversy still surrounds the concept of polys as a premalignant state, a considerable body of evidence (see review by Sherlock et al. (1975» suggests that this is likely to be the case. Raised enzyme levels in uninvolved mucosa adjacent to a carcinoma have previously been reported by Marsden and Dawson (1974) . These workers felt that their observations could be explained by mechanical compression of the surrounding mucosa by the tumour. The subsequent reduction in oxygen and substrate supply caused the cells to compensate by raising enzyme levels. We do not think that this is a likely explanation for our results, for two reasons. Firstly, it has been shown that if tissue culture cells are nutritionally deprived, the cyclic':AMP'level rises (Sheppard and Bannai, 1974) rather than falls. Secondly, it is well established that a relationship exists in vitro between lower levels of cyclic-AMP and a reduction in the degree of control of cell proliferation (Ryan and Heidrick, 1974) . This situation might be expected to be an early step in the process of malignant transformation of cells in vivo.
It is interesting to note that we found no difference in the cyclic-AMP levels between normal and carcinomatous mucosa. The majority of previous animal and human cancer studies have reported that the cyclic-AMP level is either unchanged (Minton et al., 1976; Stowe et al., 1977) or elevated (Cohen and Chan, 1975; Minton et al., 1976; Guerinot et al., 1977) in tumours. One previous study (De Rubertis et al., 1976) on carcinoma of the human colon, however, reported that the cyclic-AMP content of tumours was lower than in adjacent normal mucosa. The discrepancy between their findings and our own may be explained by the fact that these previous workers used material obtained at resection. As a consequence of this procedure, specimens were subjected to a delay of about 30 minutes before freezing. It is well known that ischaemia and trauma considerably affect cyclic-AMP levels (Mayer et al., 1974) . Another factor that may be involved in the discrepancy is the composition of the biopsy specimens used. In the present study, any specimens that were shown, histologically, to contain large amounts of fibrous tissue in relation to the total number of malignant epithelial cells were excluded. It is not known whether this procedure was followed in the previous study (De Rubertis et al., 1976) .
It would be premature to speculate why cyclic-AMP levels in the carcinoma specimens were not reduced because it is becoming increasingly evident that the intracellular metabolism of cyclic-A MP is a very involved and complex process. It seems that not only are the absolute levels of cyclic-AMP important in determining its action, but also other factors, which modulate these levels. These are such things as compartmentalisation, and interaction with other molecules, for example, cyclic guanosine 3', 5'monophosphate, ionised calcium, and proteins (Earp and Steiner, 1978) .
Another factor that could have affected the interpretation of our results arises from the selection of individuals who made up the 'normal' group. All these patients presented at the clinic with a history of rectal bleeding or diarrhoea. Therefore, none was completely healthy, and it is not known what effect these conditions could have had on cyclic-AMP levels. It might be argued, however, that this effect was not operating to any great extent, since the mean level in the 'diseased' group, in which previous rectal bleeding and diarrhoea had been severe, was not significantly higher than that in the normal group.
Our results indicate that the cyclic-AMP level in a single biopsy specimen would be unsuitable as a biochemical marker for screening for early cancerous changes in the large bowel. Although the mean level for histologically involved mucosa from the 'carcinoma' group was significantly lower than that in mucosa from the 'normal' group, the distributions did overlap and it was not possible on the basis of a single observation decisively to place a specimen in one particular group. However, when cyclic-AMP levels from adjacent uninvolved and involved mucosa were compared in individual cancer patients, a very interesting trend emerged. In 70 % of the patients investigated, the level in the uninvolved mucosa was lower than in the carcinoma. This observation may thus have appl ication in colorectal cancer for delineating the extent of the lesion or for monitoring the effects of therapy. In view of the findings of Marsden and Dawson (1974) of abnormal biochemical changes up to 10 ern from the lesion, further investigations are necessary to establish if cyclic-AMP levels remain depressed at distances greater than 3-4 em from the tumour, or increase to those values found for normal mucosa.
